Genscript Biotech Corporation
HKEX:1548.HK
12.1 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -350.979 | -226.851 | -358.712 | -204.945 | -96.912 | 21.216 | 26.123 | 26.17 | 17.504 | 6.175 | 6 |
| Depreciation & Amortization
| 74.046 | 61.183 | 45.864 | 32.331 | 20.36 | 12.334 | 6.615 | 5.042 | 4.685 | 4.703 | 4.494 |
| Deferred Income Tax
| 0 | -88.983 | -26.125 | 67.237 | 11.677 | -215.259 | 236.009 | 1.906 | 2.253 | 0.253 | 1.135 |
| Stock Based Compensation
| 60.591 | 65.154 | 39.691 | 17.637 | 10.782 | 8.852 | 2.811 | 1.836 | 3.348 | 3.284 | 0.417 |
| Change In Working Capital
| -86.906 | 23.829 | -13.566 | -84.874 | -22.459 | 206.407 | -238.82 | -3.742 | -5.601 | -3.537 | 1.052 |
| Accounts Receivables
| -116.988 | 38.066 | 1.569 | -69.909 | -14.041 | 211.809 | -235.875 | -2.519 | -5.006 | -3.164 | -1.392 |
| Inventory
| -3.928 | -14.237 | -15.135 | -14.965 | -8.418 | -5.402 | -2.945 | -1.223 | -0.595 | -0.373 | -0.16 |
| Accounts Payables
| 0 | -106.778 | -144.604 | -31.488 | -74.754 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -29.736 | 106.778 | 144.604 | 31.488 | 74.754 | -3.271 | 5.888 | 2.537 | -3.354 | 3.164 | 2.604 |
| Other Non Cash Items
| -47.565 | 45.376 | 176.058 | 21.521 | 46.597 | 274.109 | 224.639 | 3.969 | -0.3 | 1.581 | 0.061 |
| Operating Cash Flow
| -286.911 | -120.292 | -136.79 | -151.093 | -29.955 | 307.659 | 21.368 | 33.275 | 19.636 | 12.206 | 12.024 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -157.713 | -216.113 | -133.044 | -121.879 | -110.371 | -70.839 | -29.215 | -8.553 | -6.711 | -7.355 | -8.418 |
| Acquisitions Net
| -12.653 | -0.914 | 78.584 | -2.067 | 100.17 | -29.485 | -1.026 | 0.071 | -2.723 | -1.953 | 0 |
| Purchases Of Investments
| -5,743.867 | -409.62 | -322.564 | -430.727 | -1,332.256 | -74.996 | -4.224 | 0 | -4.087 | -30.447 | 0 |
| Sales Maturities Of Investments
| 5,660.107 | 187.693 | 243.98 | 462.988 | 1,232.086 | 0.83 | 0.131 | 0 | 6.81 | 32.4 | 0 |
| Other Investing Activites
| -103.844 | -4.342 | -79.504 | -8.481 | -98.262 | -19.472 | -2.117 | 0.167 | -0.111 | -3.712 | -2.496 |
| Investing Cash Flow
| -357.728 | -443.296 | -212.548 | -100.166 | -208.633 | -193.962 | -36.451 | -8.315 | -4.099 | -9.114 | -10.914 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -49.782 | -7.388 | -74.935 | -30.595 | -20.405 | -10.502 | 0 | -1.237 | 0 | -15.142 | 0 |
| Common Stock Issued
| 1,030.168 | 423.307 | 951.229 | 459.561 | 3.735 | 253.972 | 2.935 | 11.277 | 76.188 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -9.46 | -7.774 | -11.475 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | -2.635 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -2.236 | 3.398 | 25.847 | 624.203 | 46.11 | 14.825 | 1.739 | -1.553 | -11.02 | 15.537 | 1.988 |
| Financing Cash Flow
| 1,068.26 | 419.317 | 902.141 | 624.203 | -2.778 | 257.322 | 2.039 | 8.487 | 65.168 | 0.395 | 1.988 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -1.217 | -12.701 | -0.89 | 3.717 | -0.795 | -0.318 | 0.437 | -0.703 | -2.622 | -0.307 | 0.699 |
| Net Change In Cash
| 422.404 | -156.972 | 551.913 | 376.661 | -242.161 | 370.701 | -12.607 | 32.744 | 78.083 | 3.18 | 3.797 |
| Cash At End Of Period
| 1,446.403 | 1,023.999 | 1,180.971 | 629.058 | 252.397 | 494.558 | 123.857 | 136.464 | 103.72 | 25.637 | 22.457 |